查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2021-2031 年亞太地區類器官服務市場報告（範圍、細分、動態和競爭分析）
市場調查報告書
商品編碼
1843397

2021-2031 年亞太地區類器官服務市場報告（範圍、細分、動態和競爭分析）

Asia Pacific Organoids Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 136 Pages | 訂單完成後即時交付

價格

亞太地區類器官服務市場預計將大幅成長，到 2031 年將達到約 23.271 億美元，高於 2024 年的 5.1583 億美元，在 2024 年至 2031 年的預測期內，年複合成長率(CAGR) 將達到 24.0%。

執行摘要和市場分析

市場分為幾個區域，包括澳洲、中國、印度、日本、韓國和亞太其他地區。該地區的快速成長受到多種因素的推動，包括類器官的普及率不斷提高、政府為提高公眾對人體類器官的認知而採取的舉措、對先進類器官產品開發和商業化的支持性監管框架，以及類器官研究資金的增加。

市場區隔分析

亞太地區類器官服務市場可按類型、應用和來源細分：

  • 依類型：市場包括腸、肝、胃、胰臟、肺、腦、腎等部分。預計到2024年，腸道部分將佔據市場佔有率的主導地位。
  • 依應用分類：應用分為發育生物學疾病、傳染病病理學、再生醫學、藥物毒性和療效測試、藥物發現和個人化醫療等。預計發育生物學疾病領域將在2024年佔據最大的市場佔有率。
  • 依來源：市場分為多能幹細胞和器官特異性成體幹細胞，預計多能幹細胞部分將在 2024 年佔據市場佔有率的首位。

市場展望

醫療保健產業的進步推動了全球對類器官的需求成長，促進了新產品的開發、收購、合作和產品發布。近期市場值得關注的發展包括：

  • 2024 年 6 月：Molecular Devices, LLC 在英國卡迪夫開設了一家新工廠，旨在利用創新的生物製程技術大規模生產患者來源的類器官 (PDO)。
  • 2024 年 5 月：InSphero 與 Genome Biologics 建立合作關係，將 3D 心臟類器官平台商業化，增強心臟病研究能力。
  • 2024 年 1 月：HUB Organoids 推出 IntegriGut Screen 服務，利用 IBD 患者來源的類器官單層來支持新型 IBD 療法的開發。
  • 2023 年 7 月：Molecular Devices 擴展了其客製化類器官線服務，以用於高通量應用。
  • 2023 年 2 月：Molecular Devices 和 HUB Organoids 之間的策略合作旨在推進 3D 生物技術以降低藥物損耗率。
  • 2022 年 12 月：Molecular Devices 收購 Cellesce Ltd.，以增強用於藥物篩選的 PDO 生產能力。
  • 2021 年 8 月：STEMCELL Technologies 與 HUB 合作，提供用於臨床前測試的組織來源的類器官。
  • 2020 年 5 月：CELLINK 與阿斯特捷利康合作開發 3D 生物列印肝類器官用於藥物研發。
  • 2020 年 2 月：InnoSer 和 OrganoTherapeutics 宣布合作將中腦類器官商業化用於帕金森氏症研究。

這些發展顯示市場前景活躍，類器官服務具有巨大的成長機會。

國家洞察

亞太類器官服務市場涵蓋澳洲、中國、印度、日本、韓國等主要國家。預計到2024年，中國將佔據最大的市場佔有率，這得益於人們對個人化醫療日益成長的興趣，這推動了類器官的研究和開發。中國值得關注的措施包括HUB與青島華大基因合作，以加強個人化醫療，以及推出搭載人腦類器官的機器人，這些都展示了類器官技術的進步。

公司簡介

亞太類器官服務市場的關鍵參與者包括 CUSABIO TECHNOLOGY LLC、Cyprio、Eurofins Scientific SE、HUB Organoids BV、InnoSer、InSphero、LABTOO、Molecular Devices, LLC、Oncodesign Services 和 Sino Biological Inc. 這些公司正在擴大產品和市場擴張產品，以增強其市場和市場擴張產品。

目錄

第1章：簡介

第2章：執行摘要

  • 關鍵見解

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第4章：亞太地區類器官服務市場格局

  • PEST分析

第5章：亞太類器官服務市場－主要市場動態

  • 亞太地區類器官服務市場－關鍵市場動態
  • 市場促進因素
    • 創新藥物篩選服務需求不斷成長
    • 個人化藥物的普及度激增
  • 市場限制
    • 缺乏熟練的專業人員
  • 市場機會
    • 增加關鍵發展
  • 未來趨勢
    • 人工智慧的融合
  • 促進因素和限制因素的影響：

第6章：亞太地區類器官服務市場 - 分析

  • 2021-2031年亞太地區類器官服務市場收入
  • 亞太地區類器官服務市場預測分析

第7章：亞太地區類器官服務市場分析－依類型

  • 腸
  • 肝
  • 胃
  • 胰臟
  • 肺
  • 腦
  • 腎
  • 其他

第8章：亞太地區類器官服務市場分析－依應用

  • 發育生物學疾病
  • 傳染病病理學
  • 再生醫學
  • 藥物毒性和療效測試
  • 藥物研發與個人化醫療
  • 其他

第9章：亞太地區類器官服務市場分析－依來源

  • 多能幹細胞
  • 器官特異性成體幹細胞

第 10 章：亞太地區類器官服務市場 - 國家分析

  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 亞太其他地區

第 11 章：產業格局

  • 概述
  • 類器官服務市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第12章：公司簡介

  • Sino Biological Inc.
  • Eurofins Scientific SE
  • Molecular Devices, LLC.
  • InSphero
  • Cyprio
  • InnoSer
  • LABTOO
  • CUSABIO TECHNOLOGY LLC
  • Oncodesign Services
  • HUB Organoids B.V. (Hubrecht Organoid Technology)

第 13 章：附錄

Product Code: BMIRE00032025

The Asia Pacific organoids services market is projected to grow significantly, reaching approximately US$ 2,327.10 million by 2031, up from US$ 515.83 million in 2024, reflecting a robust compound annual growth rate (CAGR) of 24.0% during the forecast period from 2024 to 2031.

Executive Summary and Market Analysis

The market is divided into several regions, including Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. The rapid growth in this region is driven by several factors, including the increasing adoption of organoids, government initiatives to promote awareness of human organoids, supportive regulatory frameworks for the development and commercialization of advanced organoid products, and a rise in funding for organoid research.

Market Segmentation Analysis

The Asia Pacific organoids services market can be segmented by type, application, and source:

  • By Type: The market includes segments such as intestine, liver, stomach, pancreas, lung, brain, kidney, and others. In 2024, the intestine segment is expected to dominate the market share.
  • By Application: The applications are categorized into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, among others. The developmental biology disease segment is anticipated to hold the largest market share in 2024.
  • By Source: The market is divided into pluripotent stem cells and organ-specific adult stem cells, with the pluripotent stem cells segment expected to lead in market share in 2024.

Market Outlook

The healthcare sector's advancements have led to increased demand for organoids globally, fostering new product developments, acquisitions, partnerships, and product launches. Recent notable developments in the market include:

  • June 2024: Molecular Devices, LLC opened a new facility in Cardiff, UK, designed for large-scale production of patient-derived organoids (PDOs) using innovative bioprocess technology.
  • May 2024: InSphero entered a partnership with Genome Biologics to commercialize a 3D Cardiac Organoid Platform, enhancing heart disease research capabilities.
  • January 2024: HUB Organoids launched IntegriGut Screen services, utilizing IBD patient-derived organoid monolayers to support the development of new IBD therapies.
  • July 2023: Molecular Devices expanded its custom organoid line service for high-throughput applications.
  • February 2023: A strategic collaboration between Molecular Devices and HUB Organoids aimed to advance 3D biology technologies to reduce drug attrition rates.
  • December 2022: Molecular Devices acquired Cellesce Ltd. to enhance PDO production capabilities for drug screening.
  • August 2021: STEMCELL Technologies partnered with HUB to provide tissue-derived organoids for preclinical testing.
  • May 2020: CELLINK collaborated with AstraZeneca to develop 3D bioprinted liver organoids for drug discovery.
  • February 2020: InnoSer and OrganoTherapeutics announced a collaboration to commercialize midbrain organoids for Parkinson's disease research.

These developments indicate a vibrant market landscape with numerous opportunities for growth in organoid services.

Country Insights

The Asia Pacific Organoids Services Market includes key countries such as Australia, China, India, Japan, South Korea, and others. China is expected to hold the largest market share in 2024, driven by the growing interest in personalized medicine, which fuels organoid research and development. Notable initiatives in China include a partnership between HUB and BGI-Qingdao to enhance personalized care and the introduction of a robot with a human brain organoid, showcasing advancements in organoid technology.

Company Profiles

Key players in the Asia Pacific organoids services market include CUSABIO TECHNOLOGY LLC, Cyprio, Eurofins Scientific SE, HUB Organoids B.V., InnoSer, InSphero, LABTOO, Molecular Devices, LLC, Oncodesign Services, and Sino Biological Inc. These companies are pursuing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Asia Pacific Organoids Services Market Landscape

  • 4.1 PEST Analysis

5. Asia Pacific Organoids Services Market - Key Market Dynamics

  • 5.1 Asia Pacific Organoids Services Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Demand for Innovative Drug Screening Services
    • 5.2.2 Surge in Popularity of Personalized Drugs
  • 5.3 Market Restraints
    • 5.3.1 Dearth of Skilled Professionals
  • 5.4 Market Opportunities
    • 5.4.1 Increasing Key Developments
  • 5.5 Future Trends
    • 5.5.1 Integration of Artificial Intelligence
  • 5.6 Impact of Drivers and Restraints:

6. Asia Pacific Organoids Services Market - Analysis

  • 6.1 Asia Pacific Organoids Services Market Revenue (US$ Million), 2021-2031
  • 6.2 Asia Pacific Organoids Services Market Forecast Analysis

7. Asia Pacific Organoids Services Market Analysis - by Type

  • 7.1 Intestine
    • 7.1.1 Overview
    • 7.1.2 Intestine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Liver
    • 7.2.1 Overview
    • 7.2.2 Liver: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Stomach
    • 7.3.1 Overview
    • 7.3.2 Stomach: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Pancreas
    • 7.4.1 Overview
    • 7.4.2 Pancreas: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Lung
    • 7.5.1 Overview
    • 7.5.2 Lung: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.6 Brain
    • 7.6.1 Overview
    • 7.6.2 Brain: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.7 Kidney
    • 7.7.1 Overview
    • 7.7.2 Kidney: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Organoids Services Market Analysis - by Application

  • 8.1 Developmental Biology Disease
    • 8.1.1 Overview
    • 8.1.2 Developmental Biology Disease: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Pathology of Infectious Disease
    • 8.2.1 Overview
    • 8.2.2 Pathology of Infectious Disease: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Regenerative Medicine
    • 8.3.1 Overview
    • 8.3.2 Regenerative Medicine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Drug Toxicity and Efficacy Testing
    • 8.4.1 Overview
    • 8.4.2 Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.5 Drug Discovery and Personalized Medicine
    • 8.5.1 Overview
    • 8.5.2 Drug Discovery and Personalized Medicine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Organoids Services Market Analysis - by Source

  • 9.1 Pluripotent Stem Cells
    • 9.1.1 Overview
    • 9.1.2 Pluripotent Stem Cells: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Organ Specific Adult Stem Cell
    • 9.2.1 Overview
    • 9.2.2 Organ Specific Adult Stem Cell: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Organoids Services Market - Country Analysis

  • 10.1 Asia Pacific
    • 10.1.1 Asia Pacific Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 Asia Pacific Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 Japan: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.2.1 Japan: Asia Pacific Organoids Services Market Share - by Type
        • 10.1.1.2.2 Japan: Asia Pacific Organoids Services Market Share - by Application
        • 10.1.1.2.3 Japan: Asia Pacific Organoids Services Market Share - by Source
      • 10.1.1.3 China: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.3.1 China: Asia Pacific Organoids Services Market Share - by Type
        • 10.1.1.3.2 China: Asia Pacific Organoids Services Market Share - by Application
        • 10.1.1.3.3 China: Asia Pacific Organoids Services Market Share - by Source
      • 10.1.1.4 India: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.4.1 India: Asia Pacific Organoids Services Market Share - by Type
        • 10.1.1.4.2 India: Asia Pacific Organoids Services Market Share - by Application
        • 10.1.1.4.3 India: Asia Pacific Organoids Services Market Share - by Source
      • 10.1.1.5 South Korea: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.5.1 South Korea: Asia Pacific Organoids Services Market Share - by Type
        • 10.1.1.5.2 South Korea: Asia Pacific Organoids Services Market Share - by Application
        • 10.1.1.5.3 South Korea: Asia Pacific Organoids Services Market Share - by Source
      • 10.1.1.6 Australia: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.6.1 Australia: Asia Pacific Organoids Services Market Share - by Type
        • 10.1.1.6.2 Australia: Asia Pacific Organoids Services Market Share - by Application
        • 10.1.1.6.3 Australia: Asia Pacific Organoids Services Market Share - by Source
      • 10.1.1.7 Rest of Asia Pacific: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.7.1 Rest of Asia Pacific: Asia Pacific Organoids Services Market Share - by Type
        • 10.1.1.7.2 Rest of Asia Pacific: Asia Pacific Organoids Services Market Share - by Application
        • 10.1.1.7.3 Rest of Asia Pacific: Asia Pacific Organoids Services Market Share - by Source

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Organoids Services Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Sino Biological Inc.
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Eurofins Scientific SE
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Molecular Devices, LLC.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 InSphero
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Cyprio
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 InnoSer
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 LABTOO
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 CUSABIO TECHNOLOGY LLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Oncodesign Services
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 HUB Organoids B.V. (Hubrecht Organoid Technology)
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Organoids Services Market Segmentation
  • Table 2. Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
  • Table 4. Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 5. Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source
  • Table 6. Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 7. Japan: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 8. Japan: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 9. Japan: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 10. China: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 11. China: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 12. China: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 13. India: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 14. India: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 15. India: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 16. South Korea: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 17. South Korea: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 18. South Korea: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 19. Australia: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 20. Australia: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 21. Australia: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 22. Rest of Asia Pacific: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 23. Rest of Asia Pacific: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 24. Rest of Asia Pacific: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 25. Recent Organic Growth Strategies in Organoids Services Market
  • Table 26. Recent Inorganic Growth Strategies in the Organoids Services Market
  • Table 27. Glossary of Terms, Organoids Services Market

List Of Figures

  • Figure 1. Asia Pacific Organoids Services Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Organoids Services Market Revenue (US$ Million), 2021-2031
  • Figure 5. Asia Pacific Organoids Services Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Intestine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Liver: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Stomach: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Pancreas: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Lung: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Brain: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Kidney: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Others: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Asia Pacific Organoids Services Market Share (%) - by Application (2023 and 2031)
  • Figure 15. Developmental Biology Disease: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Pathology of Infectious Disease: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Regenerative Medicine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Drug Discovery and Personalized Medicine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Others: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Asia Pacific Organoids Services Market Share (%) - by Source (2023 and 2031)
  • Figure 22. Pluripotent Stem Cells: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 23. Organ Specific Adult Stem Cell: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. Asia Pacific Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 25. Japan: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. China: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 27. India: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 28. South Korea: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 29. Australia: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 30. Rest of Asia Pacific: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 31. Growth Strategies in Organoids Services Market